ResearcherBC Cancer AgencyNo recent work listed

Yuzhuo Z. Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9749-8591; OpenAlex author ID A5100665235. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

A personalized mRNA vaccine has exhibited potential in the treatment of pancreatic cancer. Last author DOI 10.1007/s44178-023-00042-z ↗
Long noncoding RNAs (lncRNAs) in pancreatic cancer progression. Last author DOI 10.1016/j.drudis.2022.05.012 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ning Kang · 1 shared paper, 2023 · strength 0.31
- Paper A personalized mRNA vaccine has exhibited potential in the treatment of pancreatic cancer. DOI 10.1007/s44178-023-00042-z ↗
Milad Ashrafizadeh · 1 shared paper, 2022 · strength 0.19
- Paper Long noncoding RNAs (lncRNAs) in pancreatic cancer progression. DOI 10.1016/j.drudis.2022.05.012 ↗
Alan Prem Kumar · 1 shared paper, 2022 · strength 0.19
- Paper Long noncoding RNAs (lncRNAs) in pancreatic cancer progression. DOI 10.1016/j.drudis.2022.05.012 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.